GLENVIEW CAPITAL MANAGEMENT, LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-13 4:39 pm Purchase | 2026-01-06 | 13G | Myriad Genetics, Inc. MYGN | GLENVIEW CAPITAL MANAGEMENT, LLC | 4,941,058 5.300% | 4,941,058 (New Position) | Filing |